Noradrenalina Tartrato Galenica Senese (Noradrenaline Tartrate)

Noradrenaline tartrate, the active ingredient in Noradrenalina Tartrato Galenica Senese, is a sympathomimetic agent presented as an injectable solution for intravenous use. It is employed to raise arterial pressure in patients with acute hypotension, septic shock, or cardiogenic shock.

GNH USA supplies Noradrenalina Tartrato Galenica Senese as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide, with a focus on quality assurance, cold‑chain logistics and regulatory compliance. Our distribution network ensures timely delivery to critical care units across Europe, Asia and the Americas.

Noradrenaline tartrate is a vasopressor used in acute circulatory failure. - Hypotension: restores arterial pressure and improves organ perfusion in patients with acute low blood pressure. - Septic shock: increases systemic vascular resistance to support hemodynamics in septic patients unresponsive to fluid resuscitation. - Cardiogenic shock: elevates blood pressure to maintain coronary perfusion in heart‑failure‑related shock.

Noradrenaline tartrate may be associated with a range of adverse reactions, from frequent to rare but serious. Common Side Effects: - Headache: transient headache related to rapid blood pressure changes. - Tachycardia: increased heart rate due to reflex sympathetic activation. - Nausea: mild gastrointestinal discomfort during infusion. Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Myocardial ischemia: reduced coronary blood flow causing chest pain. - Tissue necrosis: severe peripheral vasoconstriction leading to skin breakdown.

When using noradrenaline tartrate, careful monitoring and specific precautions are essential to minimize risks. - Monitor blood pressure: continuous arterial pressure monitoring is required during infusion. - Adjust dose cautiously: titrate to target mean arterial pressure to avoid excessive hypertension. - Assess cardiac function: evaluate for ischemia before and during therapy. - Use with caution in peripheral vascular disease: increased risk of limb ischemia. - Avoid rapid bolus administration: deliver as a controlled infusion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline tartrate can interact with several medications, influencing its pressor effect or safety profile. Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis when combined. - Tricyclic antidepressants: additive pressor effects increase risk of severe hypertension. - Beta‑blockers: can blunt the desired tachycardic response and alter hemodynamic goals. Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasoconstriction and raise blood pressure excessively. - Diuretics: abrupt withdrawal can potentiate hypotension during therapy. - Inhaled anesthetics: may modify vascular response and require dose adjustments.